ComplianceReady: Automated Security & Compliance Trust-Hub for MicroSaaS

For a compliance conscious buyer, option B is not really a phase you skip through, it is closer to how this category has to be sold at any stage. Pharmacovigilance and clinical trials teams are not going to self serve sign up for training software on faith, they need to trust the vendor before they trust the product, and that trust gets built through a person, not a landing page. Public launch for this buyer mostly just adds noise and support burden before you have proof it converts.On how many pilots before public launch makes sense, I would think about it less as a fixed number and more as whether you have enough pilots to write a specific case study for each sub segment you plan to target, pharma, biotech, CRO. Three pilots that are all pharma teaches you less than one pilot each across the three, since the objections and buying triggers differ by segment even within the same regulated space.The identification part is the easier half here, actually. CRO and biotech companies list their compliance and training processes publicly more often than you would expect, on their own site or in job postings for compliance roles. I do outreach for a different niche the same way, an agent that finds companies matching a profile and crawls their site for real context before drafting outreach, and a regulated niche like yours is actually a good fit for that approach since the buying signals tend to be visible if you know where to look.

For compliance-heavy buyers like pharma, Option B hands down. These people aren't going to self-serve into an unknown tool that touches their regulatory workflows. They want to talk to someone, ask about data handling, maybe loop in legal first. 3-5 paid pilots gives you something public launch can't: the exact words your buyers use internally to justify the purchase. That becomes your landing page copy and outreach messaging. I'd do 5 before opening signup publicly. And the feedback is better too, fewer data points but each one from someone who actually has the problem.